22 May 2013
Keywords: mylan, swings, 2nd-qtr, loss, merck, usa-based, swung
Article | 18 August 2008
USA-based Mylan swung to a loss in the second quarter of 2008, due to the cost of the generic drugs unit ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 August 2008
© 2013 thepharmaletter.com